Ares Commercial Real Estate (NYSE:ACRE – Get Free Report) had its price target lowered by equities researchers at UBS Group from $5.25 to $3.75 in a research note issued on Wednesday,Benzinga reports. The firm presently has a “neutral” rating on the real estate investment trust’s stock. UBS Group’s price objective would suggest a potential upside of 3.73% from the company’s current price.
Other equities analysts also recently issued research reports about the company. JPMorgan Chase & Co. cut their price objective on Ares Commercial Real Estate from $6.00 to $5.50 and set a “neutral” rating on the stock in a research report on Thursday, February 13th. JMP Securities restated a “market perform” rating on shares of Ares Commercial Real Estate in a research note on Thursday, February 13th. StockNews.com upgraded Ares Commercial Real Estate from a “sell” rating to a “hold” rating in a report on Tuesday, December 17th. Finally, Keefe, Bruyette & Woods dropped their price target on Ares Commercial Real Estate from $5.50 to $4.50 and set a “market perform” rating on the stock in a research report on Monday, April 7th. One analyst has rated the stock with a sell rating and six have issued a hold rating to the stock. Based on data from MarketBeat.com, Ares Commercial Real Estate presently has a consensus rating of “Hold” and an average target price of $5.19.
View Our Latest Analysis on ACRE
Ares Commercial Real Estate Trading Down 1.2 %
Insider Activity
In other Ares Commercial Real Estate news, VP Anton Feingold sold 7,615 shares of the company’s stock in a transaction that occurred on Friday, January 31st. The stock was sold at an average price of $5.68, for a total value of $43,253.20. Following the sale, the vice president now owns 78,360 shares in the company, valued at approximately $445,084.80. This represents a 8.86 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this link. Corporate insiders own 1.80% of the company’s stock.
Hedge Funds Weigh In On Ares Commercial Real Estate
Institutional investors and hedge funds have recently modified their holdings of the business. FMR LLC increased its stake in Ares Commercial Real Estate by 211.0% during the 3rd quarter. FMR LLC now owns 7,741 shares of the real estate investment trust’s stock worth $54,000 after buying an additional 5,252 shares in the last quarter. BNP Paribas Financial Markets lifted its stake in shares of Ares Commercial Real Estate by 17.1% in the third quarter. BNP Paribas Financial Markets now owns 11,733 shares of the real estate investment trust’s stock worth $82,000 after buying an additional 1,711 shares in the last quarter. State Street Corp boosted its position in Ares Commercial Real Estate by 2.3% during the third quarter. State Street Corp now owns 1,052,314 shares of the real estate investment trust’s stock worth $7,627,000 after acquiring an additional 23,845 shares during the last quarter. Jane Street Group LLC grew its stake in Ares Commercial Real Estate by 19.1% during the 3rd quarter. Jane Street Group LLC now owns 71,772 shares of the real estate investment trust’s stock valued at $502,000 after acquiring an additional 11,511 shares in the last quarter. Finally, Barclays PLC lifted its stake in Ares Commercial Real Estate by 279.8% in the 3rd quarter. Barclays PLC now owns 69,821 shares of the real estate investment trust’s stock worth $489,000 after purchasing an additional 51,435 shares in the last quarter. Hedge funds and other institutional investors own 41.34% of the company’s stock.
About Ares Commercial Real Estate
Ares Commercial Real Estate Corporation, a specialty finance company, originates and invests in commercial real estate (CRE) loans and related investments in the United States. It provides a range of financing solutions for the owners, operators, and sponsors of CRE properties. The company originates senior mortgage loans, subordinate debt and preferred equity products, mezzanine loans, and other CRE investments, including commercial mortgage-backed securities.
Featured Stories
- Five stocks we like better than Ares Commercial Real Estate
- 3 Healthcare Dividend Stocks to Buy
- Viking Therapeutics Stock Pops But Struggles to Hold Gains
- Using the MarketBeat Dividend Tax Calculator
- Qualcomm Stock Just Earned a Fresh Buy Rating—Get Excited
- Why Are These Companies Considered Blue Chips?
- Meta Stock Holds Upside Potential as Analysts Cut Price Targets
Receive News & Ratings for Ares Commercial Real Estate Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ares Commercial Real Estate and related companies with MarketBeat.com's FREE daily email newsletter.